Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
- Status
- RECRUITING
- Phase
- PHASE2
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
- Status
- RECRUITING
- Phase
- NA
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Personalized Medicine for Advanced Biliary Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
RP-6306 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Intravesical BCG vs GEMDOCE in NMIBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
- Status
- COMPLETED
- Phase
- PHASE2